Tag: cannabis
FSD Pharma Closes Prismic Pharma Acquisition: ‘A Paradigm Shift In The Overall Outlook Of The Company’
| Benzinga

FSD Pharma Inc. announced this week it closed a deal to acquire Prismic Pharmaceuticals, a U.S.-based specialty pharmaceutical company dedicated to addressing the opioid crisis. Through the utilization of its micro-PEA platform, the company seeks to develop novel, non-addictive prescription drugs. Such formulations impact the endocannabinoid system. This means that lower doses of drugs can be used […]

NextUp: Cannabis Pharma Entrepreneur Raza Bokhari
| Philadelphia Magazine

Who: Raza Bokhari came to Philadelphia from Pakistan nearly three decades ago after he earned his doctor of medicine degree from the University of Punjab, Rawalpindi Medical College. A brief tenure at a start-up clinical lab in North Philadelphia drove his desire to step away from his surgery scalpel and delve deeper into the entrepreneurial side of […]

FSD Pharma bolsters its board of directors with a pair of fresh faces
| Proactive Investors

FSD Pharma Inc (CSE:HUGE) (OTCMKTS:FSDDF) is beefing up its board of directors, the company announced Wednesday. James Datin, CEO of the bioanalytics lab BioAgilytix, and Robert Ciaruffoli, the co-founder and vice chairman of the 100-member angel investor network Broad Street Angels, are joining the board.